Evidence map›Paper›PMID 27604705›Full record

ReviewDer Urologe. Ausg. A2017

[Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics].

S Hofbauer, C Kalogirou, F Roghmann, A-K Seitz, S Vallo, F Wezel, T Worst, R Nawroth

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S HofbauerUniversitätsklinik für Urologie, Medizinische Universität Wien, Wien, Österreich.
C KalogirouKlinik und Poliklinik für Urologie und Kinderurologie, Universitätsklinikum Würzburg, Würzburg, Deutschland.
F RoghmannUniversitätsklinik für Urologie, Marien Hospital Herne, Ruhr-Universität Bochum, Herne, Deutschland.
A-K SeitzKlinik und Poliklinik für Urologie, Klinikum rechts der Isar der TU-München, Ismaninger Str. 22, München, Deutschland.
S ValloKlinik für Urologie, Universitätsklinik Frankfurt, Goethe Universität Frankfurt, Frankfurt, Deutschland.
F WezelKlinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Ulm, Deutschland.
T WorstKlinik für Urologie, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Deutschland.
R NawrothKlinik und Poliklinik für Urologie, Klinikum rechts der Isar der TU-München, Ismaninger Str. 22, München, Deutschland. roman.nawroth@tum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In January 2015, the research group "bladder cancer research" was founded as part of the GeSRU Academics research initiative. A general challenge to work successfully in a novel network structure is to identify common scientific topics and technical expertise in the group. Thus, one of the first tasks was to learn about current research projects from members within the group in order to address a project that suits the group's expertise. The following review summarizes three different directions that are key projects in Urologic Departments at German Universities that will be the basis to start fruitful collaborations.

Indexed as

Intersectoral CollaborationModels, OrganizationalOrganizational ObjectivesUrinary Bladder NeoplasmsGermanyHumansMedical OncologyUrologyBiomarkerCirculating tumor DNADiagnostics (liquid biopsy)Genomic InstabilityMicroRNA

Identifiers

PMID27604705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.